Goodman et al developed a model for identifying a bacteremic patient with an isolate that could be an extended-spectrum beta-lactamase (ESBL) producing organism. This can help to identify a pateint who should be placed in isolation or receive appropriate antibiotics. The authors are from the Johns Hopkins University, the University of Maryland and the University of Pennsylvania.